These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 2424840)
1. Immunological evidence for functional rather than structural mimicry by a Shigella flexneri Y polysaccharide-mimetic peptide. Borrelli S; Hossany RB; Pinto BM Clin Vaccine Immunol; 2008 Jul; 15(7):1106-14. PubMed ID: 18463226 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of Molecular Serotyping Assays for Shigella flexneri Directly on Stool Samples. Liu J; Pholwat S; Zhang J; Taniuchi M; Haque R; Alam M; Ochieng JB; Jones JA; Platts-Mills JA; Tennant SM; Houpt E J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33239379 [No Abstract] [Full Text] [Related]
3. Molecular Modeling of the Hlozek J; Owen S; Ravenscroft N; Kuttel MM Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33147882 [TBL] [Abstract][Full Text] [Related]
4. Bacteriophage Sf6 Tailspike Protein for Detection of Kunstmann S; Scheidt T; Buchwald S; Helm A; Mulard LA; Fruth A; Barbirz S Viruses; 2018 Aug; 10(8):. PubMed ID: 30111705 [TBL] [Abstract][Full Text] [Related]
5. Genetic, structural, and antigenic analyses of glycan diversity in the O-linked protein glycosylation systems of human Neisseria species. Børud B; Aas FE; Vik A; Winther-Larsen HC; Egge-Jacobsen W; Koomey M J Bacteriol; 2010 Jun; 192(11):2816-29. PubMed ID: 20363948 [TBL] [Abstract][Full Text] [Related]
6. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Levine MM; Kotloff KL; Barry EM; Pasetti MF; Sztein MB Nat Rev Microbiol; 2007 Jul; 5(7):540-53. PubMed ID: 17558427 [TBL] [Abstract][Full Text] [Related]
7. Identification, characterization, and variation in expression of two serologically distinct O-antigen epitopes in lipopolysaccharides of Campylobacter fetus serotype A strains. Brooks BW; Robertson RH; Lutze-Wallace CL; Pfahler W Infect Immun; 2001 Dec; 69(12):7596-602. PubMed ID: 11705938 [TBL] [Abstract][Full Text] [Related]
8. Molecular and phenotypic characterization of potentially new Shigella dysenteriae serotype. Coimbra RS; Lenormand P; Grimont F; Bouvet P; Matsushita S; Grimont PA J Clin Microbiol; 2001 Feb; 39(2):618-21. PubMed ID: 11158117 [TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of the O-specific lipopolysaccharide biosynthesis region (rfb) of Escherichia coli K-12 W3110: identification of genes that confer group 6 specificity to Shigella flexneri serotypes Y and 4a. Yao Z; Valvano MA J Bacteriol; 1994 Jul; 176(13):4133-43. PubMed ID: 7517390 [TBL] [Abstract][Full Text] [Related]
10. Quality of commercially produced Shigella serogrouping and serotyping antisera. Evins GM; Gheesling LL; Tauxe RV J Clin Microbiol; 1988 Mar; 26(3):438-42. PubMed ID: 3281972 [TBL] [Abstract][Full Text] [Related]
11. Use of monoclonal antibodies to type Shigella flexneri in Bangladesh. Carlin NI; Rahman M; Sack DA; Zaman A; Kay B; Lindberg AA J Clin Microbiol; 1989 Jun; 27(6):1163-6. PubMed ID: 2666435 [TBL] [Abstract][Full Text] [Related]
12. Acetylation of O-specific lipopolysaccharides from Shigella flexneri 3a and 2a occurs in Escherichia coli K-12 carrying cloned S. flexneri 3a and 2a rfb genes. Yao Z; Liu H; Valvano MA J Bacteriol; 1992 Dec; 174(23):7500-8. PubMed ID: 1280255 [TBL] [Abstract][Full Text] [Related]
13. Shigella flexneri O-antigen epitopes: chemical and immunochemical analyses reveal that epitopes of type III and group 6 antigens are identical. Carlin NI; Wehler T; Lindberg AA Infect Immun; 1986 Jul; 53(1):110-5. PubMed ID: 2424840 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type I and type III:6,7,8 antigens, group 6 antigen, and a core epitope. Carlin NI; Lindberg AA Infect Immun; 1986 Jul; 53(1):103-9. PubMed ID: 2424839 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type IV, V, and VI antigens, group 3,4 antigen, and an epitope common to all Shigella flexneri and Shigella dysenteriae type 1 stains. Carlin NI; Lindberg AA Infect Immun; 1987 Jun; 55(6):1412-20. PubMed ID: 2437036 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies specific for O-antigenic polysaccharides of Shigella flexneri: clones binding to II, II:3,4, and 7,8 epitopes. Carlin NI; Lindberg AA J Clin Microbiol; 1983 Nov; 18(5):1183-9. PubMed ID: 6196376 [TBL] [Abstract][Full Text] [Related]